18 March, 2025Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
4 March, 2025Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
20 January, 2025Amid the buzz at JP Morgan conference, Sofinnova Partners' Antoine Papiernik is optimistic
11 December, 2024Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
3 December, 2024AAVantgarde Bio announces FDA Orphan Drug Designation for AAVB-081 for the treatment of Usher Syndrome type 1B Retinitis Pigmentosa